randomized [resa]
DOUBLE BLIND [resa]
Study [mnob]
Evaluate [ftcn]
effects [qlco]
Estrogen Replacement [topp]
Reduced [qlco]
Continuous [idcn]
Combined [qlco]
Hormone [horm]
Therapy Preparation [hlca]
Containing [ftcn]
mg% [qnco]
Oestradiol valerate [horm, phsu, strd]
mg% [qnco]
dienogest [horm, phsu, strd]
Metabolism [orgf]
postmenopausal [tmco]
Women [popg]
objectives [inpr]
Evaluate [ftcn]
IMPACT [gngm]
Estrogen Replacement Therapy [topp]
Reduced [qlco]
Continuous [idcn]
Combined [qlco]
Hormone [horm]
Preparation [ftcn]
Containing [ftcn]
mg% [qnco]
Oestradiol valerate [horm, phsu, strd]
mg% [qnco]
dienogest [horm, phsu, strd]
Metabolism [orgf]
Methods [inpr]
randomized [resa]
Double-Blind Study [resa]
mg% [qnco]
dienogest [horm, phsu, strd]
Compared [acty]
Reference [idcn]
Preparation [ftcn]
Containing [ftcn]
mg% [qnco]
17 beta-Estradiol [horm, phsu, strd]
mg% [qnco]
Norethisterone acetate [horm, phsu, strd]
E2 [gngm]
Neta [fngs]
Primary [qlco]
Variable [qlco]
i e [diap, inpr]
Ratio [qnco]
Cholesterol, HDL [bacs, lipd]
baseline [bodm]
Evaluations [ftcn]
Planned [ftcn]
secondary [neop]
variables [qlco]
Lipid [lipd]
Parameters [fndg]
Haemostasis [ortf]
Carbohydrate Metabolism [moft]
treatment [ftcn]
Cholesterol, HDL [bacs, lipd]
Levels [qlco]
Decreased [qnco]
mg% [qnco]
dienogest [horm, phsu, strd]
Group [idcn]
E2 [gngm]
Neta [fngs]
Group [idcn]
treatment [ftcn]
Ratio [qnco]
Cholesterol, HDL [bacs, lipd]
baseline [bodm]
mg% [qnco]
dienogest [horm, phsu, strd]
E2 [gngm]
Neta [fngs]
Geometric Mean [qnco]
Primary [qlco]
Efficacy [qlco]
Variable [qlco]
Ratio [qnco]
Geometric Mean [qnco]
Treatments [topp]
mg% [qnco]
dienogest [horm, phsu, strd]
E2 [gngm]
Neta [fngs]
One-sided [spco]
Confidence Limit [qnco]
inferiority [socb]
bound [spco]
P-Value [qnco]
Cholesterol, HDL2 [bacs, strd]
Increased [qnco]
mg% [qnco]
dienogest [horm, phsu, strd]
Decreased [qnco]
E2 [gngm]
Neta [fngs]
treatment [ftcn]
Cholesterol, HDL3 [bacs, strd]
Decreased [qnco]
mg% [qnco]
dienogest [horm, phsu, strd]
E2 [gngm]
Neta [fngs]
treatment [ftcn]
Haemostasis [ortf]
Carbohydrate [carb]
variables [qlco]
Very [qlco]
treatment [ftcn]
Group [idcn]
thi [euka]
Study [mnob]
Estrogenic preparation [horm, phsu, strd]
Reduced [qlco]
HRT [topp]
Containing [ftcn]
mg% [qnco]
Oestradiol valerate [horm, phsu, strd]
mg% [qnco]
dienogest [horm, phsu, strd]
IMPACT [gngm]
Lipid [lipd]
variables [qlco]
Minimal [qlco]
Seen [qlco]
haemostatic [ortf]
Carbohydrate [carb]
variables [qlco]
